View in EDS PDF Full Text

Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.

Saved in:
Bibliographic Details
Title: Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.
Authors: Jung SH; Department of Biochemistry, IRCGP, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee CK; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Kwon WS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Yun S; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea., Jung M; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Kim HS; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Chung HC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Chung YJ; Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea. yejun@catholic.ac.kr., Rha SY; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea. rha7655@yuhs.ac.
Source: Yonsei medical journal [Yonsei Med J] 2023 Sep; Vol. 64 (9), pp. 531-540.
Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I
Journal Info: Publisher: Yonsei University Country of Publication: Korea (South) NLM ID: 0414003 Publication Model: Print Cited Medium: Internet ISSN: 1976-2437 (Electronic) Linking ISSN: 05135796 NLM ISO Abbreviation: Yonsei Med J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37634629
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jung+SH%22">Jung SH</searchLink>; Department of Biochemistry, IRCGP, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+WS%22">Kwon WS</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yun+S%22">Yun S</searchLink>; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Jung+M%22">Jung M</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Chung+HC%22">Chung HC</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Chung+YJ%22">Chung YJ</searchLink>; Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea. yejun@catholic.ac.kr.<br /><searchLink fieldCode="AU" term="%22Rha+SY%22">Rha SY</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Sondang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea. rha7655@yuhs.ac.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220414003%22">Yonsei medical journal</searchLink> [Yonsei Med J] 2023 Sep; Vol. 64 (9), pp. 531-540.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Yonsei+University%22">Yonsei University </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>0414003 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1976-2437 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2205135796%22">05135796 </searchLink><i>NLM ISO Abbreviation: </i>Yonsei Med J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37634629
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3349/ymj.2023.0096
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 531
    Titles:
      – TitleFull: Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jung SH
      – PersonEntity:
          Name:
            NameFull: Lee CK
      – PersonEntity:
          Name:
            NameFull: Kwon WS
      – PersonEntity:
          Name:
            NameFull: Yun S
      – PersonEntity:
          Name:
            NameFull: Jung M
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Chung HC
      – PersonEntity:
          Name:
            NameFull: Chung YJ
      – PersonEntity:
          Name:
            NameFull: Rha SY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1976-2437
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Yonsei medical journal
              Type: main
ResultId 1